- Home
- SPB vs WVE Comparison
SPB vs WVE Comparison
Compare SPB & WVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPB
- WVE
- Stock Information
- Founded
- SPB 1906
- WVE 2012
- Country
- SPB United States
- WVE Singapore
- Employees
- SPB N/A
- WVE N/A
- Industry
- SPB Industrial Machinery/Components
- WVE Biotechnology: Pharmaceutical Preparations
- Sector
- SPB Miscellaneous
- WVE Health Care
- Exchange
- SPB Nasdaq
- WVE Nasdaq
- Market Cap
- SPB 2.5B
- WVE 2.4B
- IPO Year
- SPB N/A
- WVE 2015
- Fundamental
- Price
- SPB $90.26
- WVE $14.35
- Analyst Decision
- SPB Buy
- WVE Strong Buy
- Analyst Count
- SPB 7
- WVE 10
- Target Price
- SPB $101.71
- WVE $21.30
- AVG Volume (30 Days)
- SPB 327.5K
- WVE 1.3M
- Earning Date
- SPB 11-15-2024
- WVE 11-12-2024
- Dividend Yield
- SPB 1.88%
- WVE N/A
- EPS Growth
- SPB N/A
- WVE N/A
- EPS
- SPB 4.10
- WVE N/A
- Revenue
- SPB $2,963,900,000.00
- WVE $53,610,000.00
- Revenue This Year
- SPB $1.96
- WVE N/A
- Revenue Next Year
- SPB $1.85
- WVE N/A
- P/E Ratio
- SPB $21.87
- WVE N/A
- Revenue Growth
- SPB 1.55
- WVE N/A
- 52 Week Low
- SPB $65.50
- WVE $3.50
- 52 Week High
- SPB $96.74
- WVE $16.74
- Technical
- Relative Strength Index (RSI)
- SPB 47.32
- WVE 54.93
- Support Level
- SPB $85.44
- WVE $12.66
- Resistance Level
- SPB $91.45
- WVE $16.71
- Average True Range (ATR)
- SPB 2.53
- WVE 1.14
- MACD
- SPB -0.27
- WVE -0.36
- Stochastic Oscillator
- SPB 47.07
- WVE 41.42
About SPB Spectrum Brands Holdings Inc.
Spectrum Brands Holdings Inc is consumer products and home essentials company. The company is a supplier of consumer batteries, residential locksets, residential builders' hardware, grooming products and personal care products. The company manages the businesses in product-focused segments; Home and Personal Care, global Pet Care, Home and Garden. The Company manufactures, markets and distributes its products globally in the North America, Europe, Middle East & Africa, Latin America, and Asia-Pacific.
About WVE Wave Life Sciences Ltd.
WAVE Life Sciences Ltd is unlocking the broad potential of RNA medicines also known as oligonucleotides, it targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISMTM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, splicing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.